InvestorsHub Logo
Followers 16
Posts 983
Boards Moderated 0
Alias Born 09/27/2013

Re: Gsdubb post# 6206

Wednesday, 03/19/2014 12:51:24 AM

Wednesday, March 19, 2014 12:51:24 AM

Post# of 106841
Taking into consideration the article I posted and BioHeart tweeted... The MD in the article is Jon George, MD, Interventional Cardiologist, Temple University School of Medicine

BioHeart then went on to tweet
Bioheart’s Scientific Advisory Board is composed of scientists, M.D.'s and Ph.D.s. See more: bit.ly/1nB8sUG

So I checked it out and saw listed:
George J. Magovern, M.D. Cardiac surgery Retired Chairman Department of Cardiothoracic Surgery Allegheny Hospital Pittsburgh, Pennsylvania

Note Pennsylvania.

So then I checked where the temple university school of medicine was and it turned out to be in Pennsylvania.

My question to you is, do you believe George J. Magovern M.D. Is Jon George, MD, just with his name disguised a bit since the information was intently kept under wraps as far as what companies phase 3 trials they were talking about?

Or am I looking to hard between the lines?? If I'm accurate, that means that continued phase 3 enrollment news is around the corner IMO.